{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,13]],"date-time":"2026-02-13T14:04:48Z","timestamp":1770991488039,"version":"3.50.1"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["AIDS Behav"],"published-print":{"date-parts":[[2010,10]]},"DOI":"10.1007\/s10461-010-9712-1","type":"journal-article","created":{"date-parts":[[2010,5,18]],"date-time":"2010-05-18T15:40:38Z","timestamp":1274197238000},"page":"1182-1189","source":"Crossref","is-referenced-by-count":46,"title":["Use of Non-Occupational Post-Exposure Prophylaxis does not Lead to an Increase in High Risk Sex Behaviors in Men Who have Sex with Men Participating in the EXPLORE Trial"],"prefix":"10.1007","volume":"14","author":[{"given":"Deborah","family":"Donnell","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Matthew J.","family":"Mimiaga","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kenneth","family":"Mayer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Margaret","family":"Chesney","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Beryl","family":"Koblin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas","family":"Coates","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2010,5,19]]},"reference":[{"issue":"21","key":"9712_CR1","doi-asserted-by":"crossref","first-page":"1485","DOI":"10.1056\/NEJM199711203372101","volume":"337","author":"DM Cardo","year":"1997","unstructured":"Cardo DM, Culver DH, Ciesielski CA, et al. A case-control study of HIV seroconversion in health care workers after percutaneous exposure. Centers for Disease Control and Prevention Needlestick Surveillance Group. N Engl J Med. 1997;337(21):1485\u201390.","journal-title":"N Engl J Med"},{"issue":"8","key":"9712_CR2","doi-asserted-by":"crossref","first-page":"591","DOI":"10.7326\/0003-4819-146-8-200704170-00010","volume":"146","author":"MS Cohen","year":"2007","unstructured":"Cohen MS, Gay C, Kashuba AD, Blower S, Paxton L. Narrative review: antiretroviral therapy to prevent the sexual transmission of HIV-1. Ann Intern Med. 2007;146(8):591\u2013601.","journal-title":"Ann Intern Med"},{"issue":"RR-2","key":"9712_CR3","first-page":"1","volume":"54","author":"DK Smith","year":"2005","unstructured":"Smith DK, Grohskopf LA, Black RJ, et al. Antiretroviral postexposure prophylaxis after sexual, injection-drug use, or other nonoccupational exposure to HIV in the United States: recommendations from the U.S. Department of Health and Human Services. MMWR Recomm Rep. 2005;54(RR-2):1\u201320.","journal-title":"MMWR Recomm Rep"},{"issue":"20","key":"9712_CR4","doi-asserted-by":"crossref","first-page":"9771","DOI":"10.1128\/JVI.74.20.9771-9775.2000","volume":"74","author":"RA Otten","year":"2000","unstructured":"Otten RA, Smith DK, Adams DR, et al. Efficacy of postexposure prophylaxis after intravaginal exposure of pig-tailed macaques to a human-derived retrovirus (human immunodeficiency virus type 2). J Virol. 2000;74(20):9771\u20135.","journal-title":"J Virol"},{"issue":"5","key":"9712_CR5","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1097\/00126334-200404150-00010","volume":"35","author":"M Schechter","year":"2004","unstructured":"Schechter M, do Lago RF, Mendelsohn AB, Moreira RI, Moulton LH, Harrison LH. Behavioral impact, acceptability, and HIV incidence among homosexual men with access to postexposure chemoprophylaxis for HIV. J Acquir Immune Defic Syndr. 2004;35(5):519\u201325.","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"5","key":"9712_CR6","doi-asserted-by":"crossref","first-page":"4265","DOI":"10.1128\/JVI.72.5.4265-4273.1998","volume":"72","author":"CC Tsai","year":"1998","unstructured":"Tsai CC, Emau P, Follis KE, et al. Effectiveness of postinoculation (R)-9-(2-phosphonylmethoxypropyl) adenine treatment for prevention of persistent simian immunodeficiency virus SIVmne infection depends critically on timing of initiation and duration of treatment. J Virol. 1998;72(5):4265\u201373.","journal-title":"J Virol"},{"issue":"5239","key":"9712_CR7","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1126\/science.270.5239.1197","volume":"270","author":"CC Tsai","year":"1995","unstructured":"Tsai CC, Follis KE, Sabo A, et al. Prevention of SIV infection in macaques by (R)-9-(2-phosphonylmethoxypropyl)adenine. Science. 1995;270(5239):1197\u20139.","journal-title":"Science"},{"issue":"4","key":"9712_CR8","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1086\/322781","volume":"184","author":"KK Rompay Van","year":"2001","unstructured":"Van Rompay KK, McChesney MB, Aguirre NL, Schmidt KA, Bischofberger N, Marthas ML. Two low doses of tenofovir protect newborn macaques against oral simian immunodeficiency virus infection. J Infect Dis. 2001;184(4):429\u201338.","journal-title":"J Infect Dis"},{"issue":"4","key":"9712_CR9","doi-asserted-by":"crossref","first-page":"1767","DOI":"10.1128\/JVI.74.4.1767-1774.2000","volume":"74","author":"KK Rompay Van","year":"2000","unstructured":"Van Rompay KK, Miller MD, Marthas ML, et al. Prophylactic and therapeutic benefits of short-term 9-[2-(R)-(phosphonomethoxy)propyl]adenine (PMPA) administration to newborn macaques following oral inoculation with simian immunodeficiency virus with reduced susceptibility to PMPA. J Virol. 2000;74(4):1767\u201374.","journal-title":"J Virol"},{"key":"9712_CR10","unstructured":"Rep MMMW. Case-control study of HIV seroconversion in health-care workers after percutaneous exposure to HIV-infected blood\u2014France, United Kingdom, and United States, January 1988-August 199444. 1995\/12\/22 ed. 1995:929\u201333."},{"issue":"9","key":"9712_CR11","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1258\/09564620260216290","volume":"13","author":"S Limb","year":"2002","unstructured":"Limb S, Kawsar M, Forster GE. HIV post-exposure prophylaxis after sexual assault: the experience of a sexual assault service in London. Int J STD AIDS. 2002;13(9):602\u20135.","journal-title":"Int J STD AIDS"},{"issue":"7","key":"9712_CR12","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1197\/j.aem.2005.01.015","volume":"12","author":"JA Linden","year":"2005","unstructured":"Linden JA, Oldeg P, Mehta SD, McCabe KK, LaBelle C. HIV postexposure prophylaxis in sexual assault: current practice and patient adherence to treatment recommendations in a large urban teaching hospital. Acad Emerg Med. 2005;12(7):640\u20136.","journal-title":"Acad Emerg Med"},{"issue":"4","key":"9712_CR13","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1097\/QAI.0b013e318162afcb","volume":"47","author":"KH Mayer","year":"2008","unstructured":"Mayer KH, Mimiaga MJ, Cohen D, et al. Tenofovir DF plus lamivudine or emtricitabine for nonoccupational postexposure prophylaxis (NPEP) in a Boston Community Health Center. J Acquir Immune Defic Syndr. 2008;47(4):494\u20139.","journal-title":"J Acquir Immune Defic Syndr"},{"key":"9712_CR14","unstructured":"Ackers ML, Buchbinder S, McKirnan D, et al. Post-exposure prophylaxis among HIV-uninfected participants in a phase III HIV vaccine efficacy trial. Paper presented at: XIV International Conference on AIDS; July, 2002; Barcelona, Spain."},{"issue":"2","key":"9712_CR15","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1097\/QAI.0b013e31815e4041","volume":"47","author":"AY Liu","year":"2008","unstructured":"Liu AY, Kittredge PV, Vittinghoff E, et al. Limited knowledge and use of HIV post- and pre-exposure prophylaxis among gay and bisexual men. J Acquir Immune Defic Syndr. 2008;47(2):241\u20137.","journal-title":"J Acquir Immune Defic Syndr"},{"key":"9712_CR16","unstructured":"Management of possible sexual, injecting-drug-use, or other nonoccupational exposure to HIV, including considerations related to antiretroviral therapy. Public Health Service statement. Centers for Disease Control and Prevention Sep 25 1998. 1057\u20135987 (Print)."},{"key":"9712_CR17","unstructured":"Martin JN, Roland ME, Bamberger JD, et al. Post-exposure prophylaxis (PEP) for sexual exposure to HIV does not lead to increases in high risk behavior: the San Francisco PEP Project Paper presented at: 8th Conference on Retroviruses and Opportunistic Infections; February 4\u20138, 2001; Chicago, Illinois."},{"issue":"5","key":"9712_CR18","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1097\/00002030-200403260-00010","volume":"18","author":"JN Martin","year":"2004","unstructured":"Martin JN, Roland ME, Neilands TB, et al. Use of postexposure prophylaxis against HIV infection following sexual exposure does not lead to increases in high-risk behavior. AIDS. 2004;18(5):787\u201392.","journal-title":"AIDS"},{"issue":"6","key":"9712_CR19","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1007\/s10461-007-9286-8","volume":"12","author":"SA Golub","year":"2008","unstructured":"Golub SA, Rosenthal L, Cohen DE, Mayer KH. Determinants of high-risk sexual behavior during post-exposure prophylaxis to prevent HIV infection. AIDS Behav. 2008;12(6):852\u20139.","journal-title":"AIDS Behav"},{"key":"9712_CR20","unstructured":"Schechter M, Lago R, Moreira RI, Mendelsohn AB, Harrison L. Behavioral impact of the availability of post-sexual-exposure chemoprophylaxis (PEP) for HIV: a prospective cohort study. 1st IAS Conference on Pathogenesis and Treatment. Vol Buenos Aires, Argentina; 2001."},{"key":"9712_CR21","unstructured":"Van der Straten A, Gomez C, Saul J, Padian N. Awareness of PEP and viral suppressive therapy have little effect on sexual risk behavior in heterosexual HIV-discordant couples. XII International Conference on AIDS. Vol Geneva, Switzerland; 1998."},{"key":"9712_CR22","doi-asserted-by":"crossref","unstructured":"Waldo CR, Stall RD, Coates TJ. Is offering post-exposure prevention for sexual exposures to HIV related to sexual risk behavior in gay men? AIDS. May 26 2000;14(8):1035\u20139.","DOI":"10.1097\/00002030-200005260-00016"},{"issue":"9428","key":"9712_CR23","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/S0140-6736(04)16588-4","volume":"364","author":"B Koblin","year":"2004","unstructured":"Koblin B, Chesney M, Coates T. Effects of a behavioural intervention to reduce acquisition of HIV infection among men who have sex with men: the EXPLORE randomised controlled study. Lancet. 2004;364(9428):41\u201350.","journal-title":"Lancet"},{"issue":"6","key":"9712_CR24","doi-asserted-by":"crossref","first-page":"926","DOI":"10.2105\/AJPH.93.6.926","volume":"93","author":"BA Koblin","year":"2003","unstructured":"Koblin BA, Chesney MA, Husnik MJ, et al. High-risk behaviors among men who have sex with men in 6 US cities: baseline data from the EXPLORE Study. Am J Public Health. 2003;93(6):926\u201332.","journal-title":"Am J Public Health"},{"issue":"6","key":"9712_CR25","doi-asserted-by":"crossref","first-page":"933","DOI":"10.2105\/AJPH.93.6.933","volume":"93","author":"MA Chesney","year":"2003","unstructured":"Chesney MA, Koblin BA, Barresi PJ, et al. An individually tailored intervention for HIV prevention: baseline data from the EXPLORE Study. Am J Public Health. 2003;93(6):933\u20138.","journal-title":"Am J Public Health"},{"issue":"13","key":"9712_CR26","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1001\/jama.280.13.1161","volume":"280","author":"ML Kamb","year":"1998","unstructured":"Kamb ML, Fishbein M, Douglas JM Jr, et al. Efficacy of risk-reduction counseling to prevent human immunodeficiency virus and sexually transmitted diseases: a randomized controlled trial. Project RESPECT Study Group. JAMA. 1998;280(13):1161\u20137.","journal-title":"JAMA"},{"issue":"1","key":"9712_CR27","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1097\/00126334-200405010-00009","volume":"36","author":"SP Buchbinder","year":"2004","unstructured":"Buchbinder SP, Metch B, Holte SE, Scheer S, Coletti A, Vittinghoff E. Determinants of enrollment in a preventive HIV vaccine trial: hypothetical versus actual willingness and barriers to participation. J Acquir Immune Defic Syndr. 2004;36(1):604\u201312.","journal-title":"J Acquir Immune Defic Syndr"}],"container-title":["AIDS and Behavior"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.springerlink.com\/index\/pdf\/10.1007\/s10461-010-9712-1","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,10,28]],"date-time":"2021-10-28T00:03:00Z","timestamp":1635379380000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10461-010-9712-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,5,19]]},"references-count":27,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2010,10]]}},"alternative-id":["9712"],"URL":"https:\/\/doi.org\/10.1007\/s10461-010-9712-1","relation":{},"ISSN":["1090-7165","1573-3254"],"issn-type":[{"value":"1090-7165","type":"print"},{"value":"1573-3254","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,5,19]]}}}